Ages Archives - World Asthma Foundation

April 29, 2016

Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11 – StreetInsider.com

Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11
StreetInsider.com
“The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of asthma …

and more »

View full post on asthma – Google News

January 26, 2014

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 5-11 Years Old With Persistent Asthma

Condition: Asthma
Interventions: Drug: Beclomethasone dipropionate; Drug: Placebo; Drug: albuterol/salbutamol 90 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

June 24, 2013

Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to

Condition: Allergic Rhinitis
Interventions: Drug: 205.5 mcg of azelastine hydrochloride; Drug: 137 mcg of azelastine hydrochloride
Sponsors: Meda Pharmaceuticals; Meda Pharmaceuticals; Novella Clinical Research
Recruiting – verified June 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days